Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1985 Jan;29(1):34-56.
doi: 10.2165/00003495-198529010-00002.

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy

Review

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy

E M Sorkin et al. Drugs. 1985 Jan.

Abstract

Terfenadine is a selective H1-histamine receptor antagonist. The lack of significant terfenadine penetration into the CNS is probably responsible for its lack of CNS effects. Terfenadine neither impairs psychomotor performance nor adversely affects subjective feelings, nor enhances the depressant effects of concomitantly administered alcohol or benzodiazepines. In controlled studies, the incidence of sedation due to terfenadine was comparable with that of placebo and significantly less than that with conventional antihistamines. Clinical studies have shown terfenadine to be comparable in efficacy with other antihistamines while being superior to placebo in alleviating the symptoms of seasonal allergic rhinitis. Additionally, there is good evidence that it is similarly as effective when used in the treatment of perennial rhinitis and histamine-mediated skin diseases. Thus, terfenadine offers a worthwhile improvement in side effect profile over 'traditional' antihistamines, and could well become an 'agent of choice' (along with other non-sedating antihistamines) in many patients in whom a histamine H1-receptor antagonist is indicated.

PubMed Disclaimer

References

    1. Arzneimittelforschung. 1982;32(9a):1167-70 - PubMed
    1. Arzneimittelforschung. 1982;32(9a):1202-3 - PubMed
    1. Br Med J (Clin Res Ed). 1984 Jul 7;289(6436):22 - PubMed
    1. Biopharm Drug Dispos. 1981 Apr-Jun;2(2):185-90 - PubMed
    1. Br J Dermatol. 1984 Jan;110(1):73-9 - PubMed

MeSH terms

LinkOut - more resources